Rapid traction in the global geriatric population coupled with increased obesity levels enable increase the prevalence of sleep apnea. World is experiencing growth in the number and proportion of old age people. AS per WHO, the number of people aged 60 years or over is projected to grow approximately 56 % between 2015 to 2030. According to estimates, prevalence of OSA is approximately 3% to 7% of the adult men, and 2 to 5% of adult women. Moreover, 80% of the patients with moderate to severe sleep apnea may be undiagnosed.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-sleep-apnea-devices-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Global sleep apnea devices market by product can be segmented as therapeutic devices, diagnostic devices. Therapeutic sleep apea devices market expected to expand at significant CAGR due to adoption of advanced technologies to treat OSA. CPAP devices are most commonly used devices to treat OSA, the pressure delivered to the airway is same during both inhalation and exhalation.
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-sleep-apnea-devices-market/#ulp-c654SbFYO64MsOhu[/URL]
Sleep apnea device market has been segmented into following regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
U.S. is accounted for majority of market share in 2015, expected to continue is revenue share in North America, owing large patient pool in country. In accordance with National Sleep Foundation statistics, about 18 million people in the U.S. suffered from sleep apnea in 2012. Favourable reimbursements policies for sleep apnea devices are enabling accelerate the market. For instance, Medicare reimbursement offers US $ 103.42 for CPAP device, HCPCS-E0601.
Europe market is driven by government initiatives to increase awareness about sleep apnea, adoption of novel treatment options able to create lucrative opportunities over the forecast period. As per European Sleep Apnea Database (ESADA) 2011, Prevalence of sleep apnea is around 2% of adult female and 4% of adult male. Sleep apnea is associated with impaired neuropsychological function, reduced social functioning and quality of life.
Asia-Pacific offers lucrative opportunities due to increased medical tourism in the emerging countries such as South Korea, China, and India. Adoption of cutting-edge technologies coupled with cost effective treatments enables witness for unlock the potential of sleep apnea devices market.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-sleep-apnea-devices-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of players in the sleep apnea devices market are SomnoMed Ltd., ResMed, Inc, Philips Healthcare, Fisher & Paykel Healthcare Ltd., Compumedics Limited, Braebon Medical Corporation, Weinmann Medical Devices GmbH, BMC Medical Co., Ltd. DeVilbiss Healthcare.
Get Full Summery@
[URL]https://www.precisionbusinessinsights.com/market-reports/global-sleep-apnea-devices-market/[/URL]
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553